共 155 条
[1]
Forouzanfar MH(2017)Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015 JAMA 317 165-182
[2]
Liu P(2019)Management of hypertension in chronic kidney disease Drugs 79 365-379
[3]
Roth GA(2018)2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension J Hypertens 36 1953-2041
[4]
Ng M(1999)Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria Lancet 354 359-364
[5]
Biryukov S(2017)Comparative efficacy and safety of antihypertensive agents for adult diabetic patients with microalbuminuric kidney disease: a network meta-analysis PLoS One 12 364-373
[6]
Marczak L(2014)Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients Cochrane Database Syst Rev 6 1033-1042
[7]
Pugh D(2019)Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease JAMA 321 1132-1140
[8]
Gallacher PJ(2019)Mendelian randomization study of ACLY and cardiovascular disease N Engl J Med 380 270-279
[9]
Dhaun N(2020)Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study Int J Epidemiol 49 957-972
[10]
Williams B(2019)Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects Circulation 140 4130-e361